Arima Genomics Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Arima Genomics's estimated annual revenue is currently $6.5M per year.
- Arima Genomics's estimated revenue per employee is $134,583
- Arima Genomics's total funding is $7M.
Employee Data
- Arima Genomics has 48 Employees.
- Arima Genomics grew their employee count by 20% last year.
Arima Genomics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 12 | -8% | N/A | N/A |
#2 | $24270M | 27863 | 21% | $4B | N/A |
#3 | $3M | 21 | 31% | N/A | N/A |
#4 | $5.4M | 33 | 22% | N/A | N/A |
#5 | $0.5M | 13 | -7% | $7.5M | N/A |
#6 | $4.1M | 25 | -4% | N/A | N/A |
#7 | $5M | 31 | N/A | N/A | N/A |
#8 | $4.8M | 29 | 4% | N/A | N/A |
#9 | $3.9M | 29 | -82% | $122M | N/A |
#10 | $1.9M | 16 | 0% | N/A | N/A |
What Is Arima Genomics?
Arima Genomics develops technologies that aim to accelerate the understanding of genome sequence and structure. For more information, please visit www.arimagenomics.com
keywords:N/A$7M
Total Funding
48
Number of Employees
$6.5M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arima Genomics News
2022-03-30 - The complete sequence of a human genome
... 70× Illumina Arima Genomics Hi-C (Hi-C) (14), BioNano optical maps (14), and single-cell DNA template strand sequencing (Strand-seq) (20) (table S1).
2022-03-30 - People in the News: New Appointments at Nautilus ...
Arima Genomics has appointed Chris Roberts as senior VP of corporate strategy. Roberts comes to Arima from Veracyte, where he led the...
2022-03-22 - Arima Genomics Closes Series B Financing to Support ...
Arima Genomics' technologies provide three-dimensional information about the genome. While most DNA sequencing methods provide linearized DNA...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.2M | 48 | 14% | N/A |
#2 | $15.3M | 48 | 4% | N/A |
#3 | $11M | 48 | -6% | N/A |
#4 | $11.4M | 48 | 0% | N/A |
#5 | $7.8M | 49 | 23% | N/A |